Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Virginia Rossi
Observed names:
V. ROSSI,
V. Rossi,
VIRGINIA ROSSI,
Virginia ROSSI
Institution:
Azienda Ospedaliero-Universitaria Careggi
Observed institutions:
Azienda Ospedaliero-Universitaria Careggi,
Azienda Ospedaliero Universitaria Maggiore della Carita,
Ospedale San Luigi Gonzaga,
University of Florence
ORCID:
0000-0002-8524-4033
Observed ORCID:
0000-0002-8524-4033
OpenAlex ID:
A5024837477
Immune Checkpoint Inhibitors in Urothelial Bladder Cancer: State of the Art and Future Perspectives
2021
·
Giandomenico Roviello
, Martina Catalano
, et al.
·
Cancers
·
72
PDF
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
2024
·
Brigida Anna Maiorano
, Massimo Di Maio
, et al.
·
JAMA Network Open
·
67
Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
2021
·
Agnese Paderi
, Roberta Giorgione
, et al.
·
Cancers
·
66
PDF
Hypoxia-Inducible Factor in Renal Cell Carcinoma: From Molecular Insights to Targeted Therapies
2024
·
Giandomenico Roviello
, Irene De Gennaro
, et al.
·
Genes
·
30
PDF
Castration-resistant prostate cancer with bone metastases: toward the best therapeutic choice
2022
·
Giandomenico Roviello
, Martina Catalano
, et al.
·
Medical Oncology
·
13
PDF
Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25)
2024
·
Elisabetta Gambale
, Marco Maruzzo
, et al.
·
Clinical Genitourinary Cancer
·
12
PDF
A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy
2021
·
Jasminka Hasic Telalovic
, Serena Pillozzi
, et al.
·
Diagnostics
·
12
Gender Matters. Sex-related Differences in Immunotherapy Outcome in Patients with Non-small Cell Lung Cancer
2022
·
Enrico Caliman
, Maria Cristina Petrella
, et al.
·
Current Cancer Drug Targets
·
11
Pembrolizumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Analysis of Prognostic Factors of Outcomes
2021
·
Carmelo Tibaldi
, Francesca Mazzoni
, et al.
·
Anti-Cancer Agents in Medicinal Chemistry
·
10
Real-world effectiveness of Avelumab maintenance in advanced urothelial carcinoma: results from the Italian multicenter MALVA study (Meet-URO 25)
2025
·
Giandomenico Roviello
, Elisabetta Gambale
, et al.
·
The Oncologist
·
5
PDF
Bone Metastases in Renal Cell Carcinoma: Impact of Immunotherapy on Survival
2023
·
ELISABETTA GAMBALE
, VALERIA EMMA PALMIERI
, et al.
·
Cancer Diagnosis & Prognosis
·
5
PDF
Analysis of molecular and clinical markers of resistance to bacillus of Calmette-Guérin immunotherapy in patients with urothelial non-muscle invasive bladder cancer
2022
·
Fabrizio DI MAIDA
, Antonio A. GROSSO
, et al.
·
Minerva Urology and Nephrology
·
5
Immune Checkpoint Inhibitor-Related Pneumonitis in Renal Cell Carcinoma: Clinical Features, Mechanisms, and Lessons from Lung Cancer
2026
·
Kristian Shtembari
, Martina Catalano
, et al.
·
Biomolecules
·
2
PDF
A Snapshot from the Italian Clinical Practice Regarding Efficacy and Utility Rate of Perioperative Chemotherapy in Muscle-invasive Bladder Cancer: The RealBLADDER Study
2025
·
ELISABETTA GAMBALE
, ROBERTA GIORGIONE
, et al.
·
In Vivo
·
2
PDF
13P First-line CEMiplimab in metastatic PENile squamous cell carcinoma: The CemPen study
2024
·
E. Gambale
, I.A. Vascotto
, et al.
·
ESMO Open
·
2
Prognostic factors in advanced colorectal carcinoma: A multifactorial analysis
2005
·
L. Forti
, S. Miraglia
, et al.
·
Journal of Clinical Oncology
·
2
Clinical and pathological predictors of early recurrence after neoadjuvant cisplatin gemcitabine in muscle invasive bladder cancer in the RealBLADDER study
2026
·
Giandomenico Roviello
, Elisabetta Gambale
, et al.
·
Scientific Reports
·
1
PDF
Predicting efficacy in patients with locally advanced/metastatic urothelial carcinoma (mUC) treated with immunotherapy using explainable machine learning approaches: the SamUR-AI trial on behalf of the Meet-URO group
2026
·
A. Rametta
, S. Ferri
, et al.
·
ESMO Real World Data and Digital Oncology
·
1
PDF
Serum Biomarkers in Bladder Cancer: NMR Metabolomics for Identification and Monitoring during Platinum-Based Therapy
2026
·
Roberta Giorgione
, Daniela Grasso
, et al.
·
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
·
1
NMR metabolomics in bladder cancer: Identification and monitoring of serum biomarkers during Pt-based treatment.
2023
·
Roberta Giorgione
, Elisabetta Gambale
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors
2018
·
Alessandro Villanucci
, Ketty Tavella
, et al.
·
Molecular and Clinical Oncology
·
1
PDF
Trastuzumab deruxtecan in HER2-expressing urothelial carcinoma: current evidence, biomarker challenges, and future therapeutic strategies
2026
·
Giandomenico Roviello
, Kristian Shtembari
, et al.
·
Expert Review of Anticancer Therapy
Oligoprogressive Prostate Cancer: Can Metastasis-Directed Therapy Prolong the Benefit of Systemic Treatment?
2026
·
Giandomenico Roviello
, Kristian Shtembari
, et al.
·
Clinical Genitourinary Cancer
PDF
Post-ASCO 2026: resident-led highlights of the most clinically relevant studies in genitourinary oncology
2026
·
Martina Izzi
, Kristian Shtembari
, et al.
·
Future Oncology
Predictive biomarkers in cancer immunotherapy for genitourinary malignancies
2026
·
Alexandra Paulet
, Kristian Shtembari
, et al.
·
Critical Reviews in Oncology/Hematology
PDF
Show more works
View as search
Works count:
36
Citation count:
321
H-index:
9
I10-index:
9
Year
Topic
Type